BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15651039)

  • 1. Viral vectors as tools to model and treat neurodegenerative disorders.
    Déglon N; Hantraye P
    J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral-based modelling and correction of neurodegenerative diseases by RNA interference.
    Raoul C; Barker SD; Aebischer P
    Gene Ther; 2006 Mar; 13(6):487-95. PubMed ID: 16319945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
    McMenamin MM; Wood MJ
    Gene Ther; 2010 Apr; 17(4):448-58. PubMed ID: 20147982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease.
    Latchman DS
    Curr Opin Mol Ther; 2005 Oct; 7(5):415-8. PubMed ID: 16248276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.
    Janus C
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():12-27. PubMed ID: 18184367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors for the treatment of neurodegenerative diseases.
    Martin-Rendon E; Azzouz M; Mazarakis ND
    Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models.
    Richardson RM; Larson PS; Bankiewicz KS
    Neurosurgery; 2008 Oct; 63(4):629-442; dicussion 642-4. PubMed ID: 18981876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral vector-mediated gene transfer for CNS disease.
    Snyder BR; Boulis NM; Federici T
    Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vectors for gene transfer to striated muscle.
    Gregorevic P; Blankinship MJ; Chamberlain JS
    Curr Opin Mol Ther; 2004 Oct; 6(5):491-8. PubMed ID: 15537050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From gene therapy to virotherapy for ovarian cancer.
    Stoff-Khalili MA; Dall P; Curiel DT
    Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.
    Poenaru L
    Ann Med; 2001 Feb; 33(1):28-36. PubMed ID: 11310936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.